Skip to Content

Chad reports slight drop in revenues

Chad reports slight drop in revenues

CHATSWORTH, Calif. - Chad Therapeutics' revenues declined slightly for the second quarter fiscal year 2006 to $5,375,000 from $6,309,000 the previous year. Chad reported that sales of oxygen conservers to domestic customers dropped 29% during the first six months of fiscal 2006 compared to the prior year due to continuing pressure on prices, as well as decreased sales to a major customer. The company's net loss for second quarter fiscal 2006 was $210,000, compared to net earnings of $455,000 for the second quarter of fiscal 2005. For the six months ending Sept. 30, 2005, revenue declined from $12,408,000 for last year's period to $11,270,000 this year. A possible silver lining: International conserver sales increased 181% during the first six months of fiscal 2006 compared to the prior year, the company reported. Also, sales of its home oxygen filling system increased 39% during that same period. In addition, Chad reported plans to bring on board Ewing Bemiss & Co., a Richmond, Va.-based private firm with investment banking experience, to evaluate further opportunities in the sleep disorder market.

Comments

To comment on this post, please log in to your account or set up an account now.